EIF2A and neurodegenerative disease: Increased levels of phosphorylated PERK (p-PERK) and phosphorylated eIF2α (p-eIF2α) were found in the brains of patients with neurodegenerative diseases, suggesting that ER stress and PERK activation may play a role in disease pathogenesis (Bell et al., 2016).